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Abstract: Adenosine is perhaps the most important and universal modulator in the brain. The current consensus is that it 
is primarily produced in the extracellular space from the breakdown of previously released ATP. It is also accepted that it 
can be released directly, as adenosine, during pathological events primarily by equilibrative transport. Nevertheless, there 
is a growing realization that adenosine can be rapidly released from the nervous system in a manner that is dependent 
upon the activity of neurons. We consider three competing classes of mechanism that could explain neuronal activity de-
pendent adenosine release (exocytosis of ATP followed by extracellular conversion to adenosine; exocytotic release of an 
unspecified transmitter followed by direct non-exocytotic adenosine release from an interposed cell; and direct exocytotic 
release of adenosine) and outline discriminatory experimental tests to decide between them. We review several examples 
of activity dependent adenosine release and explore their underlying mechanisms where these are known. We discuss the 
limits of current experimental techniques in definitively discriminating between the competing models of release, and 
identify key areas where technologies need to advance to enable definitive discriminatory tests. Nevertheless, within the 
current limits, we conclude that there is evidence for a mechanism that strongly resembles direct exocytosis of adenosine 
underlying at least some examples of neuronal activity dependent adenosine release. 
INTRODUCTION 
  Adenosine is one of the most important modulators in the 
brain. Originally discovered as a powerful vasodilator [21], 
adenosine acts as: an endogenous somnogen [3]; a retaliatory 
neuroprotective analyte during metabolic stress [16, 54]; a 
modulator of pain pathways [56]; a modulator of spinal mo-
tor output [7, 18]; and in many regions of the brain a depres-
sor of synaptic transmission. 
Receptors 
  Adenosine can act at 4 types of G-protein coupled recep-
tors, respectively the A1, A2A, A2B and A3 receptors (for com-
prehensive reviews see [26, 50]). A1 receptors are mostly 
inhibitory mainly coupling through the Gi/o type G proteins 
to inhibit adenylate cyclase. In some instances they can cou-
ple through Gq/11 to stimulate phospholipase C. The A2A and 
A2B receptors are broadly similar to each other with the A2A
receptor being found in the central nervous system and the 
A2B receptor in peripheral tissues. The A2A receptor is largely 
excitatory coupling through Gs to stimulate adenylate cy-
clase. The A3 receptor is once again largely inhibitory and 
couples through Gi/o to inhibit adenylate cylase and stimulate 
phospholipase C. 
Mechanisms of Adenosine Production 
  A common consensus implicit in the literature is that 
adenosine is not released via exocytosis. Instead there are 
two main pathways for its appearance and production in the 
extracellular space. Firstly it can arise from previously re-
leased ATP through the actions of several different enzyme  
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families collectively called the ectonucleotidases, reviewed 
by[29,53, 64-66]. These families comprise: the E-NTPDases 
(of which there are at least 4 members located in the plasma 
membrane and which have a variety of substrate specificities 
and convert ATP to either ADP or AMP); the E-NPPases (of 
which there are 6 putative members, 3 of which have been 
shown to be capable of converting ATP to AMP with one 
variant also able to produce adenosine from AMP); the ecto-
alkaline phosphatases (which have extremely broad substrate 
specificities) and the ecto-5’-nucleotidase, which converts 
AMP to adenosine. There is no doubt that this is an impor-
tant route of extracellular adenosine production. It has been 
well documented in for example spinal cord where ATP is 
produced during motor activity (see later). This route is also 
important for the adenosine tone that is present within the 
brain, which arises from prior release of ATP from astro-
cytes [49].  
  However adenosine can also be released directly. This 
direct release seems to occur during pathologies such as 
oxygen-glucose deprivation (ischemia, [28]) and during hy-
percapnic acidosis in spinal cord [48]. The mechanism of 
release is uncertain, but is assumed to involve transporters. 
However there is conflicting evidence: for the most part the 
equilibrative transporters apparently act to remove adenosine 
from the extracellular space –their inhibition causes a rise in 
extracellular adenosine [19, 28]. This inward concentration 
gradient for adenosine may occur because adenosine kinase, 
a cytoplasmic enzyme, keeps the free intracellular adenosine 
concentration very low [5]. When this enzyme is inhibited, 
either pharmacologically [28, 60] or for example during hy-
percapnia in spinal cord [48], adenosine can be released via
the equilibrative transporters. 
  There is also growing evidence (reviewed below) that 
adenosine can be released, under non-pathological condi-
tions, by the activation of neurones by brief trains of action 330    Current Neuropharmacology, 2008, Vol. 6, No. 4 Wall and Dale 
potentials. This potentially important route for adenosine 
release links neural activity (action potentials) with a mecha-
nism to feedback and inhibit the activated pathway (via A1
receptor activation) and the possibility of inhibiting neigh-
bouring pathways, depending on the extent of adenosine 
diffusion. It is also possible that the released adenosine can 
produce changes in blood vessel diameter [41] and thus link 
neural activity with blood flow, although several other me-
diators released from astrocytes have also been proposed [44, 
59, 68]. Although the exact mechanism of how the adenosine 
is released remains unclear, there are hints that adenosine 
could be directly released by exocytosis. Below we outline 
some simple schemes that could account for activity-depen-
dent adenosine release, discuss the way these schemes could 
be experimentally distinguished and summarise data from a 
number of different studies.  
Activity-Dependent Adenosine Release –Possible Mecha-
nisms 
  Around 75% of energy expenditure in the brain is de-
voted to signalling [2]. One possible reason for activity-
dependent adenosine release could be depletion of ATP lev-
els during neural signalling. This depletion would however 
have to result in elevated levels of cytoplasmic adenosine to 
allow subsequent transport to the extracellular space. This 
may be significant during more global activity in the brain 
such as epileptic seizures, but seems an unlikely explanation 
for adenosine release that can be seen following brief activa-
tion of signalling (on the order of seconds) in small popula-
tions of neurons. Furthermore such a metabolic source of 
adenosine would be released in a Ca
2+-independent manner 
and by a transport dependent process. As there is evidence 
for transport-independent and Ca
2+-dependent mechanisms 
of adenosine release (see below), further mechanisms of ac-
tivity-dependent release of adenosine must be considered. 
  We therefore consider three further simple schemes to 
provide potential mechanisms for the activity-dependent 
release of adenosine (Fig. (1)). All these schemes require 
exocytosis, as it is the simplest way of linking activity with 
release, and thus the release of adenosine in all cases will 
exhibit both calcium and action potential dependence. How-
ever only in case 3 will adenosine be packaged in vesicles 
and directly released by exocytosis. We shall consider these 
three schemes in detail and outline the critical experimental 
tests required to distinguish between them. 
SCHEME 1 (EXTRACELLULAR METABOLISM OF 
ATP)  
  Under this scheme ATP, released by exocytosis, is bro-
ken down in the extracellular space by ectoATPases and 
nucleotidases to produce adenosine. This scheme includes 
the direct exocytosis of ATP from neurones and also exocy-
tosis of ATP from glia in response to a transmitter, for ex-
ample glutamate, released from neurones. Rapid ATP release 
will be followed by the slower appearance of adenosine in 
the extracellular space. The reason for this slower dynamic 
of adenosine production is that ATP catabolism is a multien-
zyme process with the final step, conversion of AMP to 
adenosine, being subject to feed-forward inhibition by ATP 
and ADP [32]. 
Fig. (1). Possible mechanisms for activity-dependent adenosine 
release.  
1) ATP is released by exocytosis (either from a neuron or glial cell) 
and subsequently metabolised in the extracellular space to produce 
adenosine. 2) An unspecified interposed transmitter (?) is released 
by exocytosis to act on a downstream cell causing the release of 
adenosine by an unknown mechanism (?). 3) Direct exocytotic re-
lease of vesicular adenosine.
  A critical test of this scheme is to examine the sensitivity 
of adenosine production to blockers of the ectoATPases 
(such as ARL 67156) and the ecto- 5’-nucleotidase (such as 
,-methylene ADP). These should diminish the production 
of adenosine and hence reduce its effects; blockade of the 
ectoATPase may also enhance any direct effects of ATP 
mediated through P2 receptors. Ideally, direct measurement 
of extracellular ATP via luciferin-luciferase chemilumines-
cence (for example [46]) or with biosensors [37] and adeno-
sine with biosensors [19, 36] or fast cyclic voltammetry [13, 
58] should be attempted. With these techniques, it may be 
possible to directly demonstrate the characteristic delays in 
adenosine production with respect to neural activity that be-
tokens extracellular conversion of ATP and the intervening 
metabolites [19, 20, 32]. 
  Thus the absence of an effect of blockade of extracellular 
ATP catabolism on adenosine production and the appearance 
of adenosine in the absence of any ATP release would elimi-
nate this scheme from consideration, subject to the caveats 
outlined below. 
SCHEME 2 (INTERPOSED TRANSMITTER) 
  Under the second scheme, an unspecified neurotransmit-
ter would be released (by exocytosis) to activate an inter-
posed cell (either a neuron or astrocyte) to produce adeno-
sine release (by some currently unclear mechanism). 
  The discriminatory test would be to block the receptors 
of the interposed transmitter (with selective antagonists) –
these should diminish adenosine release. The difficulty is 
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known; therefore even use of an exhaustive battery of an-
tagonists may not be conclusive if these all provide negative 
results. There are many examples where activation of gluta-
mate receptors has been shown to release adenosine (for re-
view see [35]). Determining whether adenosine release is 
sensitive to glutamate receptor blockade is thus an important 
test, however other types of transmitter should also be exam-
ined including the cannabinoids, which can induce changes 
in intracellular Ca
2+ in neurons and astrocytes [22]. If the 
interposed cell were to be an astrocyte, then it is vital to di-
rectly image astrocytic signalling (via intracellular Ca
2+) to 
demonstrate the efficacy or otherwise of the antagonist regi-
men in preventing astrocytic activation. 
  An alternative and more general way of testing this 
scheme is to try and inactivate the putative interposed cell. If 
this is a neuron, then massive activation of GABAAreceptors 
will shunt the membrane and hence the excitatory effects of 
the putative interposed transmitter, without greatly diminish-
ing release of the transmitter itself. A difficulty arises if the 
interposed cell is an astrocyte as these may not possess 
GABAA receptors. Some authors have used fluorocitrate and 
fluoroacetate to alter astrocytic function [39]. We have con-
cerns as to the specificity of such treatments and whether 
they are adequate tests of astrocytic involvement. Other ways 
to test the involvement of interposed astrocytes that may be 
of utility would be their selective loading with Ca
2+ chelators 
(possible in brain slices derived from young rodents [17]) or 
the use of genetically altered mice where astrocytic signal-
ling has been selectively disrupted [49]. 
  However we conclude that is very hard to completely 
eliminate this scheme as an explanation of adenosine release 
–at any point a positive result will demonstrate that this 
scheme applies, e.g. sensitivity of adenosine release to glu-
tamate receptor antagonism, but a series of negative results 
to all of these tests cannot completely exclude this explana-
tion either. 
SCHEME 3 (DIRECT EXOCYTOSIS OF ADENOSINE) 
  The final mechanism is the direct release of adenosine by 
exocytosis. This implies the loading of adenosine into synap-
tic vesicles –perhaps hard to achieve if cytoplasmic adeno-
sine levels are very low, which can be the case for cells in 
which adenosine kinase is strongly expressed. However a 
recent report suggests that adenosine kinase is largely absent 
from hippocampal neurons of adult rat supporting the plausi-
bility of vesicular loading [57]. 
  Under this scheme it is necessary to show the release of 
adenosine in the absence of the release of ATP as well as 
insensitivity to blockers of ATP catabolism. However con-
clusive demonstration of adenosine exocytosis is difficult. 
One obvious reason for this is that adenosine does not act 
through a ligand-gated channel thus the possibility, which 
would definitively and easily demonstrate this scheme, of 
observing adenosinergic miniature postsynaptic currents or 
potentials, does not exist. 
  An excellent, but difficult, test is to block exocytosis 
from the cell type hypothesized to release adenosine –this 
may be possible with genetically altered rodent models (for 
example [63]), however these data would not necessarily 
exclude involvement of an interposed cell (scheme 2). Dem-
onstration of the presence of adenosine in synaptic vesicles 
would provide supporting evidence for this hypothesis. Ul-
timately however, definitive evidence will require demon-
stration of adenosine release via exocytosis from isolated 
cells (either acutely or in culture). Further developments in 
adenosine sensing technologies may make this test possible. 
EXAMPLES OF ACTIVITY DEPENDENT ADENO-
SINE RELEASE 
 There are a number of regions of the central nervous sys-
tem where activity-dependent adenosine release has been 
described. We will examine them and discuss the evidence 
for which scheme may underlie the release. 
Xenopus Spinal Motor Pattern Generation 
  ATP and adenosine modulate spinal motor pattern gen-
erationinXenopusembryos. ATP is excitatory acting through 
P2Y receptors to inhibit voltage gated K
+ channels [9, 18]. 
Adenosine depresses motor activity, and acts by inhibiting 
voltage-gated Ca
2+ channels [8, 18]. The dynamic balance 
between these modulators changes with time during swim-
ming activity and results in a gradual slowing and spontane-
ous termination of the motor pattern. This system involves 
the release and production of both ATP and adenosine –their 
postsynaptic effects can be demonstrated via the use of an-
tagonists. Direct demonstration of ATP release from isolated 
neurons [10], and from the spinal cord during locomotion 
has been achieved [37]. Adenosine production during swim-
ming has also been demonstrated [19, 36]. This has the pre-
dicted slow dynamic arising from extracellular catabolism of 
ATP [19, 20, 36]. Thus this is a clear example of adenosine 
release arising via scheme 1. 
Hippocampal CA1 Synapses 
  Glutamatergic synapses onto CA1 pyramidal neurones 
are modulated by the activation of A1 receptors leading to 
presynaptic inhibition [24, 55]. Mitchell et al. (1993) [42] 
provided the first evidence for a form of activity-dependent 
adenosine release at these synapses. They showed that the 
activation of an excitatory pathway onto CA1 neurones leads 
to the transient depression of fEPSPs evoked in another in-
dependent pathway (Fig. (2)). This inhibition was produced 
by the release of adenosine (presumably from a component 
within or activated by the stimulated pathway) and the sub-
sequent activation of presynaptic A1 receptors (as the inhibi-
tion could be blocked by the adenosine receptor antagonist 
theophylline). Although the depression was seen with a sin-
gle stimulus it was much more pronounced with a train of 
stimuli (16-23, at 100 Hz) presumably as more adenosine is 
released [42]. The degree of inhibition was also increased if 
the extracellular breakdown of adenosine was reduced with 
an adenosine deaminase inhibitor (EHNA) and thus pre-
sumably greater concentrations of adenosine can diffuse to 
the depressed pathway [42]. Similar results have also been 
observed using organotypic slices, where the short-term de-
pression of a single CA1 pathway (with a 10 Hz, 5 s stimula-
tion) was partly reversed by blocking A1 receptors [6]. Thus 
the adenosine released can inhibit both the stimulated path-
way and diffuse to inhibit neighbouring pathways. Function-
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stimulation can block the consolidation of LTP [1, 14]. Ac-
tivity-dependent adenosine release is also seen during sei-
zures generated in the hippocampus and acts to terminate the 
seizures [25]. 
  What is the mechanism of this activity-dependent adeno-
sine release? Addition of a 5’-ectonucleotidase inhibitor 
(200-500 M , methylene-ADP) had no effect on the de-
gree of synaptic depression [6, 42] suggesting that the 
adenosine does not arise from the extracellular metabolism 
of ATP (eliminating scheme 1). The adenosine release per-
sisted in 10 M dipyridamole [6] suggesting that it may not 
arise from cytoplasmic translocation via a carrier protein, 
nevertheless this possibility is not completely excluded as a 
dipyridamole-insensitive carrier could still be involved. 
There is currently no data on whether the release of an inter-
posed transmitter is required for adenosine release or indeed 
whether the adenosine release involves exocytosis. However, 
Manzoni et al. (1994) [38] have shown that NMDA receptor 
activation causes the release of adenosine and subsequent 
inhibition of CA1 synapses via A1 receptor activation. This 
adenosine release persisted in the presence of , methylene 
ADP (500 M) and thus does not appear to involve the 
breakdown of extracellular ATP. Slice superfusion experi-
ments suggest that this adenosine release is Ca
2+ dependent 
[15] and thus may involve exocytosis. The obvious question 
is: does activity-dependent release of adenosine produced by 
synaptic stimulation require NMDA receptor activation (im-
plying a scheme 2 type mechanism)? This currently remains 
unknown but would be relatively easy to answer by stimulat-
ing CA1 synapses with trains, with and without an NMDA 
receptor antagonist.  
  What is the source of the adenosine? Brundege and 
Dunwiddie (1996) [11] showed that loading CA1 pyramidal 
neurones with adenosine (via a patch pipette) led to adeno-
sine release and the presynaptic inhibition of glutamatergic 
synaptic transmission on to the cell. However loading the 
neurones with enzyme inhibitors and nucleotides had no ef-
fect on the degree of synaptic transmission suggesting that 
pyramidal cells do not readily form adenosine from endoge-
nous sources [12]. Manzoni et al. (1994) [38] suggested that 
the NMDA receptor mediated adenosine release could be via
inhibitory interneurones as it was reduced by enkephalin, 
which selectively inhibits interneurones.  
The Calyx of Held 
  The Calyx of Held is a giant nerve terminal in the audi-
tory brainstem forming an axo-somatic glutamatergic syn-
apse onto a principal cell in the medial nucleus of the trape-
zoid body (MNTB). Transmission at this synapse is de-
pressed by the activation of presynaptic adenosine A1 recep-
tors [4] an effect that declines during postnatal development 
[33]. Kimura et al. (2003) [33] showed, with an A1 receptor 
antagonist (8 CPT), that there is no tone of adenosine con-
tinually activating the A1 receptors. However during high 
frequency trains (10 Hz), blocking A1 receptors relieved a 
proportion of the synaptic depression, suggesting that adeno-
sine release occurred during the train (Fig. (3)) [33]. By 
comparing the degree of inhibition relieved by 8 CPT (~13 
%) and the adenosine concentration-response curve it was 
possible to estimate the concentration of adenosine released, 
which reached ~ 5 M [33]. 
  What is the mechanism for this activity-dependent adeno-
sine release? Blocking extracellular ATP metabolism (with 
the ectoATPase inhibitor ARL 67156, 50 M) had no effect 
suggesting the adenosine does not arise from the extracellu-
lar breakdown of ATP (eliminating scheme 1, [62]). This 
was supported by the inability of the luciferin-luciferase as-
say to detect any ATP release following a 200 Hz train [62]. 
However there is currently no information on whether the 
adenosine release requires exocytosis and whether the re-
lease of an interposed transmitter is required. The most likely 
source of the adenosine is the excitatory terminals (which 
release glutamate and express the A1 receptors) and thus the 
adenosine acts to depress excitatory synaptic transmission 
(and presumably its own release) via autoreceptors [62].  
Fig. (2). Transient inhibition of hippocampal CA1 field EPSPs 
by conditioning stimulation. 
Field excitatory postsynaptic potentials (fEPSPs) were measured in 
the apical dendrites of CA1 and were stimulated by an electrode 
placed in the stratum radiatum of CA2. A conditioning electrode 
was placed in the stratum radiatum of CA1 near the subiculum. A) 
Amplitudes of fEPSPs evoked every 30 seconds. At 5 minute inter-
vals, a conditioning train consisting of 5 pulses was applied ending 
200 ms prior to the fEPSP. B) fEPSPs from the shaded area of A. 
Responses are shown to test stimulation alone (T) and 200 msec 
after the conditioning pulses (C-P T). fEPSPs preceded by the con-
ditioning pulses were reduced 15-20 % relative to the baseline. 
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Fig. (3). Presynaptic inhibition by endogenous adenosine is in-
creased during high frequency stimulation at the Calyx of Held 
Excitatory postsynaptic currents (EPSCs) were recorded from 
MNTB principal neurons in P5-7 rats in response to stimulation of 
input fibres. A) Averaged EPSCs during a train of 30 stimuli at 10 
Hz. The first EPSC (I0) and the 27th-30th EPSCs, before (black) 
and during (red) application of CPT (0.5 M), are shown (superim-
posed). B) Synaptic depression during 10 Hz stimulation. EPSCs 
during a train are normalized in amplitude to the first EPSC. Mean 
amplitudes and S.E.M.s of EPSCs (from five cells with significant 
increase in mean amplitude of 20th- 30th EPSCs (Iss) after CPT 
application, D) during 10 Hz stimulation are plotted, before ( ) and 
during ( ) CPT application. C, Time plot of I0 and Iss in a cell. 
Bath application of CPT (bar) increased Iss with no effect on I0.
Mean amplitude of Iss before CPT application is indicated by a 
dashed line. D) mean amplitudes of Iss before and after application 
of CPT in seven cells. Difference was statistically significant (*P < 
0.05) in five cells shown in B, but insignificant in two other cells. 
Taken with permission from [33].
Parallel Fibre-Purkinje Cell Synapses in the Cerebellum  
  Glutamatergic parallel fibre to Purkinje cell synapses are 
inhibited by the activation of presynaptic adenosine A1 re-
ceptors [34, 52]. Adenosine biosensors [36] placed on the 
surface of the molecular layer of transverse slices (above the 
parallel fibre tracts) can detect adenosine release following 
trains (5-80 Hz) of stimuli (Fig. (4)) [61]. The amount of 
adenosine released was increased by increasing the number 
of stimuli and by the higher frequencies of stimulation. Suf-
ficient adenosine was released to inhibit parallel fibre-
Purkinje cell synaptic transmission, an effect blocked by A1
receptor antagonists [61]. 
  What is the mechanism of adenosine release? As with the 
hippocampus and Calyx of Held, the amount of adenosine 
released was not reduced by blocking extracellular ATP 
breakdown (with Evans Blue, ARL 67156 or , -methylene 
ADP at 100 M) [61]. Furthermore ATP biosensors (detec-
tion limit ~ 60 nM, [37]) placed either in the slice or in the 
same position as the adenosine biosensor did not detect ATP 
release following trains of stimuli [61]. Release of ATP by 
local electroporation [c.f. 30] led to rapid adenosine produc-
tion (via extracellular metabolism) but the proportion of ATP 
broken down to adenosine was relatively small (~20 %) sug-
gesting that complete and rapid ATP breakdown was ex-
tremely unlikely [61]. Thus it appears that the source of 
adenosine is not extracellular ATP eliminating scheme 1. 
The adenosine release was reversibly blocked by tetrodo-
toxin (action potential dependent) and was also Ca
2+ depend-
ent [61]. Thus the release mechanism appears to involve 
exocytosis and thus probably occurs either by scheme 2 (in-
terposed transmitter release) or by scheme 3 (direct release 
of adenosine by exocytosis). Adenosine release was not re-
duced by blocking a number of transmitter receptors (includ-
ing glutamate, noradrenaline and 5 HT) and was not reduced 
by shunting neurones and glia by activating GABAA recep-
tors with muscimol [61]. Furthermore release was not re-
duced by blocking adenosine transport via ENT1 and ENT2 
(with NBTI/dipyridamole). Thus it appears unlikely that the 
adenosine release occurs by scheme 2. The simplest explana-
tion is that the release mechanism is direct exocytosis of 
adenosine. 
  What is the source of the released adenosine? The posi-
tion of the stimulating and recording electrodes, along a 
beam of parallel fibres, are ideal to stimulate and record re-
lease from parallel fibres. Furthermore, activation of presyn-
aptic receptors on parallel fibre terminals (GABAB mGluR4 
and A1 receptors) causes a reversible reduction in adenosine 
release [61]. The restricted location of mGluR4 receptors in 
the cerebellum (only present on parallel fibre terminals [40]), 
strongly suggests that adenosine release occurs from the ter-
minals of parallel fibres. Block of A1 receptors (with 8 CPT) 
markedly increased the amount of adenosine released sug-
gesting that the A1 receptor acts as an autoreceptor, control-
ling the amount of adenosine and glutamate released [61].  
OTHER SYNAPSES 
  In the rat hypothalamic supraoptic nucleus, blocking A1
receptors had no effect at a low frequency synaptic stimula-
tion (0.05-0.5 Hz) but at 1 Hz, the time-dependent depres-
sion of inhibitory and excitatory transmission was prevented 
by A1 receptor block [47]. Thus it appears that activity-
dependent adenosine release occurs during trains of activity 
in a similar fashion to the other synapses.  
Limitations of Studies 
  There are at least three experimental limitations that pre-
vent the full elucidation of the mechanisms underlying activ-
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Low Efficacy of the Inhibitors of Extracellular ATP Ca-
tabolism 
  Critical for the evaluation of scheme 1, is to test whether 
adenosine arises from the extracellular breakdown of ATP 
by using inhibitors of the ectoATPases and ecto-5’-nucleo-
tidase. This is fine if the inhibitor has a positive effect (re-
ducing the amount of adenosine released). However a lack of 
effect, may be a false negative as the agents may not have 
Fig. (4). Properties of adenosine release at cerebellar parallel fibre-Purkinje cell synapses. 
Biosensor recordings were made from transverse cerebellar slices from P21-28 rats. Biosensors were laid on the surface of the molecular 
layer and adenosine release was evoked with a stimulating electrode placed on the same beam of parallel fibres. A) Superimposed current 
traces from adenosine and null biosensors following electrical stimulation (20 Hz, 5 s). The lack of signal on the null sensor indicates the 
current on the adenosine biosensor is due to purine detection and is not non-specific. B) Superimposed traces from an adenosine biosensor 
placed on the surface of the molecular layer and an ATP biosensor placed within the molecular layer (under the adenosine sensor). Following 
stimulation, although adenosine was measured, no ATP could be detected. C) Superimposed current traces from an adenosine biosensor in 
control, CNQX (10 M) and AP5 (50 M, to block glutamate receptors) and TTX (0.5 M, to block action potentials). The adenosine re-
leased by stimulation was blocked by TTX but was insensitive to the block of ionotropic glutamate receptors. D) Superimposed current 
traces from an adenosine biosensor in control and in the presence of the mGluR4 receptor agonist L-AP4 (50 M). The amount of adenosine 
released following stimulation was reversibly reduced by the activation of mGluR4 receptors. E) Superimposed traces from an adenosine 
biosensor in control and in the presence of the A1 receptor antagonist 8CPT (1 M). Block of A1 receptors markedly increased the amount of 
adenosine released. F) Current model of adenosine release. Trains of parallel fibre action potentials release adenosine (Ado, shaded area) 
which can diffuse between fibres. Inset, close-up of parallel fibre-Purkinje cell synapses (dotted area in A). Following an action potential 
train, active fibres release adenosine and glutamate. Adenosine feeds back to inhibit its own release and glutamate release, via A1 receptors. 
Adenosine may also diffuse to inhibit release from neighbouring inactive fibres (lateral inhibition). The release of adenosine is also inhibited 
by mGlu4R receptor activation (which could occur by feedback of released glutamate) and GABAB receptor activation. A-E modified from 
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effectively blocked the breakdown of ATP. This is plausible, 
as the widely used NTPDase inhibitor, ARL 67156, has rela-
tively low efficacy and is a competitive antagonist. High 
concentrations of ATP will overcome its relatively weak 
blocking action [28, 43, 61]. In cerebellum, the 5’-nucleo-
tidase inhibitor ,-methylene ADP appears the most effec-
tive agent in preventing the production of adenosine [61] but 
its action is competitive and thus will be overcome by high 
levels of substrate. By contrast ,-methylene ADP is inef-
fective at blocking the ecto-5’-nucleotidase in Xenopus and 
acts instead as an agonist at a P2Y1 receptor [9]. Indeed sev-
eral P2 receptor antagonists such as suramin, PPADS, 
NF449, NF279 and RB-2 are effective blockers of at least 
some E-NTPDases [31, 45, 68], complicating interpretations 
over the use of these compounds. 
  There are convenient methods to analyze the extracellular 
catabolism of ATP in situ and in brain slices [9, 28, 60, 61]. 
These allow determination of the efficacy of putative inhibi-
tors of the ectoATPases and ecto-5’-nucleotidase and we 
strongly recommend their use to give greater credibility to 
the interpretations resulting from the use of these com-
pounds. 
  Many studies only measure adenosine release indirectly 
via the inhibition of synaptic transmission by the activation 
of presynaptic A1 receptors. Because the A1 receptors have a 
very high affinity for adenosine (EC50 600-750 nM for de-
pressing CA1 EPSPs, [23]), it is probable that only a small 
proportion of the extracellular ATP has to be broken down to 
produce significant A1 receptor activation. Thus if the inhibi-
tors are only partially effective, enough adenosine may still 
be produced to cause synaptic inhibition. Although this prob-
lem can be reduced by combining the inhibition of ATP 
breakdown with other methods such as biosensors [60, 61] 
and luciferin-luciferase [62] to detect ATP release, there 
always remains the doubt that if no ATP is detected it is be-
cause of extremely rapid breakdown that has not been pre-
vented by the inhibitor. Thus future studies require either the 
development of new more effective NTPDase inhibitors (for 
example see [43]) or the use of transgenic technology to pre-
vent extracellular ATP breakdown. 
INDIRECT MEASUREMENTS OF ADENOSINE RE-
LEASE  
  Most of the studies of activity-dependent adenosine re-
lease, indirectly measure the adenosine released by the acti-
vation of A1 receptors and the subsequent inhibition of syn-
aptic transmission. There are two major problems with this 
method: firstly any procedure that modulates adenosine re-
lease but also changes synaptic transmission cannot be ex-
amined. For example procedures such as removing extracel-
lular Ca
2+ or blocking action potentials (with tetrodotoxin) 
cannot be used as they will also block synaptic transmission 
and thus the influence of adenosine on transmission can no 
longer be measured. Secondly, the quantification of the 
amount of adenosine is difficult as the degree of synaptic 
inhibition is not always linearly related to the amount of 
adenosine present (at the bottom of the concentration curve 
and at the top where receptors are saturated). This problem 
can be avoided by combining measurements of synaptic in-
hibition with a direct real-time measure of adenosine release 
using for example a biosensor [27, 61]. 
EXCLUSION OF AN INTERPOSED TRANSMITTER 
  It is difficult to distinguish whether adenosine is directly 
released by exocytosis or whether there is an interposed 
transmitter (schemes 2 and 3). This is because there are a 
large number of possible transmitter candidates and it is dif-
ficult to test them all. Wall & Dale (2007) [61] used the 
shunting of neurones and glia with the GABAA receptor 
agonist muscimol to exclude release from interposed neu-
rones and glia. Although Purkinje cells were effectively 
shunted, the effects on glia remain unclear although they do 
express GABAA receptors [51]. Future strategies could in-
clude the use of transgenic mice, where exocytosis from glia 
is blocked (dominant-negative SNARE, [49]) or transmission 
at specific synapses is blocked (for example by selective 
Table 1.  Summary Comparison of Activity-Dependent Adenosine Release in the Four Circumstances Discussed in the Text. The 
first three examples are candidates for direct activity-dependent release of adenosine. (*) In Xenopus activity dependent 
adenosine release occurs via extracellular conversion of ATP released as a result of self-sustained activity within the spi-
nal motor network and the issues of Ca
2+- and action potential-dependence are implicit. (?) denotes that the dependence of 
mechanism respectively on Ca
2+, TTX or interposed transmitter has not been tested. 
 Trains  of  Stimuli 
Required for Release 
Ca
2+ Dependent  Action Potential 
Dependent 
(TTX)
Evidence for  
ATP Release 
Evidence for 
an Interposed 
Transmitter 
Hippocampal CA1 synapses  Yes
a,b ?  ?  No
a,b ? 
Calyx of Held 
MNTB 
Yes
c,d ?  ? No
d ? 
Cerebellar parallel fibre-
Purkinje cell 
Yes
e Yes
e Yes
e No
e No
e
Xenopus spinal cord  Yes
f * *  Yes
g,h
a) [42], 
b) [6], 
c) [33], 
d) [61], 
e) [60], 
f) [18], 
g) [10], 
h) [37] 336    Current Neuropharmacology, 2008, Vol. 6, No. 4 Wall and Dale 
tetanus toxin expression, [62]) or the measuring of adenosine 
release from cultures of specific cell types.
CONCLUSIONS 
  There is growing evidence that activity-dependent adeno-
sine release occurs in several different brain areas and thus is 
perhaps a common feature of many central neural circuits. In 
all of the reports, a train of electrical activity (usually in glu-
tamatergic neurones), releases adenosine which feeds back to 
inhibit transmitter release in the stimulated pathway. In many 
cases, although the adenosine does not arise from extracellu-
lar ATP breakdown (but see the caveats above) it is still un-
clear where and how the adenosine is released. In the cere-
bellum, where the story is most complete [61], the simplest 
mechanism that accounts its release is the direct exocytosis 
of adenosine from parallel fibres, although future experi-
ments are required to prove this definitively. The use of bio-
sensors in the cerebellum has allowed much greater insight 
into the properties of adenosine release compared to studies 
which only monitored adenosine release indirectly (via syn-
aptic inhibition). For example, cerebellar adenosine release is 
modulated by the activation of presynaptic receptors such as 
GABAB and mGluR4 and adenosine itself can feedback to 
inhibit its own release (via A1 receptor activation). Thus the 
adenosine release appears more like conventional transmitter 
release than perhaps expected and in many ways can be 
treated as a slow postsynaptic potential. Furthermore, the 
complexity of adenosinergic signalling is enhanced, as the 
amount of adenosine released will not only depend on the 
stimulus but also can be potentially modulated by several 
feedback mechanisms. Thus the full understanding of how 
adenosine is released and its effects on neural circuit behav-
iour will require the combination of electrophysiology, bio-
sensor technology, computational studies and the develop-
ment of new tools, for example effective NTPDase blockers 
and transgenic technology.  
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